The lyophilized material with vaccinia viral activity of 4.5 - 6.0 ffu per lg 1,04-31,3; ; tablet; <TableGroup colSep="0" cols="2" rowSep="0"> <Colspec colName="c0"/> <Colspec colName="c1"/> <Tbody> <Row> <entry align="left"> Peptone</entry> <entry align="right"> 0,12-3,8;</entry> </Row> <Row> <entry align="left"> Zhelatoza</entry> <entry align="right"> 0,06-1,9;</entry> </Row> <Row> <entry align="left"> saccharose</entry> <entry align="right"> 10,1-11,55;</entry> </Row> <Row> <entry align="left"> buffer</entry> <entry align="right"> 0,001-0,027;</entry> </Row> <Row> <entry align="left"> calcium stearate</entry> <entry align="right"> 1,94-2,0;</entry> </Row> <Row> <entry align="left"> Vanillin</entry> <entry align="right"> 0,17-0,2;</entry> </Row> </Tbody> </TableGroup> </TableFormula> </Table> ; Lactose balance to 100%. Acid-shell tablet before its four-fold by covering the surface of the nucleus comprises shellac, oleic acid, ammonia water 25% solution and distilled water at the following contents of components in parts by weight: shellac - 10.0; acid oleinovaya- 2.0; aqueous ammonia 25% -3.0; distilled water - 85.0."/> <meta property="og:document:type" content="pdf"/> <meta property="og:document:page" content="9999"/> <meta name="Robots" contect="all"> <link rel="canonical" href="https://www.zhangqiaokeyan.com/patent-detail/06130439120619.html"/> <link rel="shortcut icon" href="https://cdn.zhangqiaokeyan.com/favicon.ico"> <link rel="alternate" media="only screen and (max-width: 640px)" href="https://m.zhangqiaokeyan.com/patent-detail/06130439120619.html"/> <title>Tableted LIVE recombinant bivaccine 'REVAKS CGT' against smallpox and hepatitis B to enteral administration
首页> 外国专利> Tableted LIVE recombinant bivaccine 'REVAKS CGT' against smallpox and hepatitis B to enteral administration

Tableted LIVE recombinant bivaccine 'REVAKS CGT' against smallpox and hepatitis B to enteral administration

机译:片剂抗天花和乙型肝炎的LIVE重组重组牛痘疫苗“ REVAKS CGT”用于肠内给药

摘要

The invention relates to medicine, in particular, to the immunology and can be used for specific prevention of infectious viral hepatitis and smallpox. The vaccine in the form of tablets with acid-resistant shell is at a low immunizing dose forming protective level of specific immunity. Bivaccine based on vaccinia virus for oral administration comprising per tablet the lyophilized viral material accumulated based on recombinant vaccinia virus strain STB №2131 with typical properties of vaccinia virus expressing preS 2-Ag HbsAg and HCV activity in a 4.5-6, 0 lg pfu per tablet, lactose, sucrose, calcium stearate, and vanillin, peptone, and zhelatozu buffer. Recombinant vaccinia virus has gained in continuous culture of animal cells in the following ratio of components per nucleus tablet (wt.%):;
<TableGroup colSep="0" cols="2" rowSep="0"> <Colspec colName="c0"/> <Colspec colName="c1"/> <Tbody> <Row> <entry align="left"> The lyophilized material with vaccinia viral activity of 4.5 - 6.0 ffu per lg</entry> <entry align="right"> 1,04-31,3;</entry> </Row> </Tbody> </TableGroup> </TableFormula> </Table> ; tablet; <Table> <TableFormula> <Title/> <TableGroup colSep="0" cols="2" rowSep="0"> <Colspec colName="c0"/> <Colspec colName="c1"/> <Tbody> <Row> <entry align="left"> Peptone</entry> <entry align="right"> 0,12-3,8;</entry> </Row> <Row> <entry align="left"> Zhelatoza</entry> <entry align="right"> 0,06-1,9;</entry> </Row> <Row> <entry align="left"> saccharose</entry> <entry align="right"> 10,1-11,55;</entry> </Row> <Row> <entry align="left"> buffer</entry> <entry align="right"> 0,001-0,027;</entry> </Row> <Row> <entry align="left"> calcium stearate</entry> <entry align="right"> 1,94-2,0;</entry> </Row> <Row> <entry align="left"> Vanillin</entry> <entry align="right"> 0,17-0,2;</entry> </Row> </Tbody> </TableGroup> </TableFormula> </Table> ; Lactose balance to 100%. Acid-shell tablet before its four-fold by covering the surface of the nucleus comprises shellac, oleic acid, ammonia water 25% solution and distilled water at the following contents of components in parts by weight: shellac - 10.0; acid oleinovaya- 2.0; aqueous ammonia 25% -3.0; distilled water - 85.0. </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> <div class="translation abstracttxt"> <span class="zhankaihshouqi fivelineshidden" id="abstract"> <span>机译:</span>本发明涉及医学,尤其涉及免疫学,可用于特异性预防传染性病毒性肝炎和天花。具有抗酸外壳的片剂形式的疫苗以低免疫剂量形成特异性免疫的保护水平。基于牛痘病毒的口服口服比伐他汀,每片包含基于重组牛痘病毒STB№2131积累的冻干病毒材料,该疫苗具有典型的牛痘病毒特性,可在4.5-6,0 lg pfu中表达preS 2-Ag HbsAg和HCV活性片剂,乳糖,蔗糖,硬脂酸钙,香兰素,蛋白ept和zhelatozu缓冲液。重组痘苗病毒在动物细胞的连续培养中获得了以下组成的比例,每核片剂的成分比例(重量%): <表格> <TableFormula> <标题/> <TableGroup colSep =“ 0” cols =“ 2” rowSep =“ 0”> <Colspec colName =“ c0” /> <Colspec colName =“ c1” /> <身体> <行> <entry align =“ left”>牛痘病毒活性为每升4.5-6.0 ffu的冻干物质</ entry> <entry align =“ right”> 1,04-31,3; </ entry> </ Row> </ Tbody> </ TableGroup> </ TableFormula> </ Table> ;片剂; <表格> <TableFormula> <标题/> <TableGroup colSep =“ 0” cols =“ 2” rowSep =“ 0”> <Colspec colName =“ c0” /> <Colspec colName =“ c1” /> <身体> <行> <entry align =“ left”>蛋白ept </ entry> <entry align =“ right”> 0,12-3,8; </ entry> </ Row> <行> <entry align =“ left”> Zhelatoza </ entry> <entry align =“ right”> 0,06-1,9; </ entry> </ Row> <行> <entry align =“ left”>蔗糖</ entry> <entry align =“ right”> 10,1-11,55; </ entry> </ Row> <行> <entry align =“ left”>缓冲区</ entry> <entry align =“ right”> 0,001-0,027; </ entry> </ Row> <行> <entry align =“ left”>硬脂酸钙</ entry> <entry align =“ right”> 1,94-2,0; </ entry> </ Row> <行> <entry align =“ left”>香兰素</ entry> <entry align =“ right”> 0,17-0,2; </ entry> </ Row> </ Tbody> </ TableGroup> </ TableFormula> </ Table> ;乳糖平衡至100%。通过覆盖核表面四倍的酸壳片剂包含虫胶,油酸,25%的氨水溶液和蒸馏水,其中以下组分的重量份含量为:虫胶-10.0;酸oleinovaya- 2.0;氨水25%-3.0;蒸馏水-85.0。 </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> </div> <div class="record"> <h2 class="all_title" id="enpatent33">著录项</h2> <div class="getdents"> <ul> <li> <p><span>公开/公告号</span><span>RU47743U1</span></p> <p><span>专利类型</span><span></span></p> </li> <li> <p><span>公开/公告日</span><span>2005-09-10</span></p> <p><span>原文格式</span><span>PDF</span></p> </li> <li> <div class="apply"> <p><span style="width: 90px;display: inline-block;">申请/专利权人</span><span id="patentee" class="threelineshidden zhankaihshouqi"> </span></p> <span class="designer hoverxs" style="display: none;">展开▼</span> </div> <p><span>申请/专利号</span><span style="width: 250px;">RU20040130657U</span></p> </li> <li> <div class="apply"> <p><span style="width: 90px;display: inline-block;">发明设计人</span><span id="patentee" class="threelineshidden zhankaihshouqi"> <a href="/search.html?doctypes=12_13&sertext=СЕРГЕЕВ А.А. (RU)&option=202">СЕРГЕЕВ А.А. (RU);</a><a href="/search.html?doctypes=12_13&sertext=САНДАХЧИЕВ Л.С. (RU)&option=202">САНДАХЧИЕВ Л.С. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ШИШКИНА Л.Н. (RU)&option=202">ШИШКИНА Л.Н. (RU);</a><a href="/search.html?doctypes=12_13&sertext=МИСТЮРИН Ю.Н. (RU)&option=202">МИСТЮРИН Ю.Н. (RU);</a><a href="/search.html?doctypes=12_13&sertext=СКАРНОВИЧ М.О. (RU)&option=202">СКАРНОВИЧ М.О. (RU);</a><a href="/search.html?doctypes=12_13&sertext=СЕРГЕЕВ А.Н. (RU)&option=202">СЕРГЕЕВ А.Н. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ВДОВИЧЕНКО Г.В. (RU)&option=202">ВДОВИЧЕНКО Г.В. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ГЕНЕРАЛОВ В.М. (RU)&option=202">ГЕНЕРАЛОВ В.М. (RU);</a><a href="/search.html?doctypes=12_13&sertext=НЕТЕСОВ С.В. (RU)&option=202">НЕТЕСОВ С.В. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ПЕТРИЩЕНКО В.А. (RU)&option=202">ПЕТРИЩЕНКО В.А. (RU);</a><a href="/search.html?doctypes=12_13&sertext=МЕЛЬНИКОВ С.А. (RU)&option=202">МЕЛЬНИКОВ С.А. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ПЕРЕКРЕСТ В.В. (RU)&option=202">ПЕРЕКРЕСТ В.В. (RU);</a><a href="/search.html?doctypes=12_13&sertext=САФАТОВ А.С. (RU)&option=202">САФАТОВ А.С. (RU);</a><a href="/search.html?doctypes=12_13&sertext=БЕКТИМИРОВ Т.А. (RU)&option=202">БЕКТИМИРОВ Т.А. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ПЛЯСУНОВ И.В. (RU)&option=202">ПЛЯСУНОВ И.В. (RU);</a><a href="/search.html?doctypes=12_13&sertext=ЕВТИН Н.К. (RU)&option=202">ЕВТИН Н.К. (RU);</a> </span></p> <span class="designer hoverxs" style="display: none;">展开▼</span> </div> <p><span>申请日</span><span>2004-10-21</span></p> </li> <li> <p style="width: 100%;"><span>分类号</span><span style="width: 80%;">A61K9/20;A61K39/12;</span> </p> </li> <li> <p style="width: 100%;"><span>国家 </span><span style="width: 93%;">RU</span></p> </li> <li><p style="width: 100%;"> <span >入库时间</span> <span>2022-08-21 22:01:47</span></p> </li> </ul> </div> </div> </div> <div class="literature cardcommon"> <div class="similarity"> <h3 class="all_title" id="enpatent66">相似文献</h3> <div class="similaritytab clearfix"> <ul > <li >专利</li> <li >外文文献</li> <li >中文文献</li> </ul> </div> <div class="similarity_details"> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/patent-detail/06120112651227.html">重组乙型肝炎抗原冻干保护剂、重组乙型肝炎抗原冻干疫苗及其制备方法</a> <b>[P]</b> . <span> 中国专利: CN112675134A </span> <span> . 2021-04-20</span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/patent-detail/061204523879.html">一种重组A型口蹄疫病毒VP1基因的塞内卡重组病毒、重组疫苗株及其制备方法和应用</a> <b>[P]</b> . <span> 中国专利: CN111996201B </span> <span> . 2021.07.13</span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/patent-detail/06130439148022.html">TABLETED LIVE RECOMBINANT BIVACCINE "REVAKS VKT" AGAINST NATURAL SMALLPOX AND HEPATITIS B AND METHOD FOR ITS PREPARING</a> <b>[P]</b> . <span> 俄罗斯专利: RU2242246C2 </span> <span> . 2004-12-20</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译: </span>对抗天然猪痘和乙型肝炎的表活重组生物疫苗“ REVAKS VKT”及其制备方法 </p> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/patent-detail/06130434184834.html">KIT OF TABLETTED ALIVE RECOMBINANT ORAL BIVACCINE AGAINST SMALLPOX AND HEPATITIS B AND METHOD FOR VACCINATION AT APPLYING THE KIT MENTIONED</a> <b>[P]</b> . <span> 俄罗斯专利: RU2302259C2 </span> <span> . 2007-07-10</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译: </span>针对小痘和乙型肝炎的片状活重组口腔生物疫苗的套件及应用该套件的疫苗接种方法 </p> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/patent-detail/06130436735269.html">SET OF TABLETS live recombinant oral bivaccine against smallpox and hepatitis B and vaccination method using these SET</a> <b>[P]</b> . <span> 俄罗斯专利: RU2005104850A </span> <span> . 2006-08-10</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译: </span>平板电脑套装针对天花和乙型肝炎的重组活疫苗口服口服疫苗以及使用这些套装的疫苗接种方法 </p> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/academic-journal-cn_journal-hainan-medical-university-english-edition_thesis/0201235033301.html">Effect of Compound Biejiaruangan Tablets combined with entecavir therapy on liver fibrosis process and immune response state in patients with chronic hepatitis b</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Qin Yang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Qin Yang,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Zhen Ma&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Zhen Ma </a> <a href="/journal-foreign-11892/" target="_blank" rel="nofollow" class="tuijian_authcolor">海南医科大学学报(英文版) .</a> <span>2018</span><span>,第005期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/academic-journal-cn_medical-university-english-edition_thesis/0201273837253.html">Effect of Compound Biejiaruangan Tablets combined with entecavir therapy on liver fibrosis process and immune response state in patients with chronic hepatitis b</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Qin Yang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Qin Yang,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Zhen Ma&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Zhen Ma </a> <a href="/journal-foreign-55375/" target="_blank" rel="nofollow" class="tuijian_authcolor">海南医科大学学报(英文版) .</a> <span>2018</span><span>,第005期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/academic-journal-cn_international-journal-hepatobiliary-pancreatic-diseases-english_thesis/0201232114617.html">Recombinant anti-HBsAg Fab blocks hepatitis B virus infection after orthotopic liver transplantation</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Tao Pan&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Tao Pan,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Li Tang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Li Tang,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Jin Yuan&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Jin Yuan,</a> <a href="/journal-foreign-11016/" target="_blank" rel="nofollow" class="tuijian_authcolor">国际肝胆胰疾病杂志(英文版) .</a> <span>2007</span><span>,第004期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/academic-conference-foreign_meeting-194351_thesis/020513149621.html">CHITOSAN COATED PLGA: POLOXAMER NANOCARRIERS FOR THE MUCOSAL DELIVERY OF THE RECOMBINANT HEPATITIS B SURFACE ANTIGEN</a> <b>[C]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Patrizia Paolicelli&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Patrizia Paolicelli,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Cecilia Prego&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Cecilia Prego,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Alejandro Sanchez&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Alejandro Sanchez,</a> <a href="/conference-foreign-194351/" target="_blank" rel="nofollow" class="tuijian_authcolor">Controlled Release Society Annual Meeting and Exposition .</a> <span>2007</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-degree-foreign_mphd_thesis/02061159162.html">The role of CXCL9 in host defense during acute viral infection of the CNS and liver in mice: Perspectives using a recombinant mouse hepatitis virus.</a> <b>[D] </b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Muse, Michael Harold.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Muse, Michael Harold. </a> <span>2007</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-journal-foreign-pmc_detail_thesis/040003041881.html">The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=D A Lee&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">D A Lee,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=G M Taylor&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">G M Taylor,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=J G Walker&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">J G Walker,</a> <span>1979</span> </span> </div> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/open-access_resources_thesis/01000132397457.html">Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Tomoji Ono&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Tomoji Ono,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Michiaki Murakoshi&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Michiaki Murakoshi,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Noriyuki Suzuki&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Noriyuki Suzuki,</a> <span>2010</span> </span> </div> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/academic-journal-cn_world-journal-gastroenterology-english_thesis/0201292763029.html">Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study</a> <b>[J]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Silvia Sookoian&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . Silvia Sookoian</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=María Alejandra Fernández&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,María Alejandra Fernández</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Gustavo Casta(n~)o&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Gustavo Casta(n~)o</a> <span> <a href="/journal-cn-52914/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 世界胃肠病学杂志:英文版 </a> </span> <span> . 2005</span><span>,第48期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/academic-conference-cn_meeting-7023_thesis/020221829478.html">重组乙肝疫苗联合干扰素对慢性乙型肝炎患者抗HBV及改善肝功能的临床研究</a> <b>[C]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=王者令&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 王者令</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=倪卫东&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,倪卫东</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=刘中景&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,刘中景</a> <span> <a href="/conference-cn-7023/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 山东中西医结合学会传染病专业委员会第三次学术会议 </a> <span> <span> . 2012</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/academic-degree-domestic_mphd_thesis/020312659629.html">抗淋病LTB-PorB核酸疫苗与重组蛋白疫苗联合免疫的免疫增强效应研究</a> <b>[A] </b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=戴志兵&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 戴志兵</a> <span> . 2010</span> </span> </div> </li> </ul> </div> </div> <!--- <div class="correlation "> <h3 class="all_title" id="enpatent77">相关文献</h3> <div class="correlationtab clearfix"> <ul> <li class="active">中文文献</li> <li>外文文献</li> <li>专利</li> </ul> </div> <div class="correlation_details"> <ul> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>8. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>9. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>10. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> </ul> <ul> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">分散型キャンパス情報ネットワークにおけるセキュリティ環境-香川大学情報ネットワークにおけるセキュリティ対策の現状と報告</a> <b>[J]</b> . <span> <a href="">河内一芳,</a> <a href="">曽根計俊,</a> <a href="">川口政秀,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">電子情報通信学会技術研究報告. 情報通信マネジメント. Information and Communication Management .</a> <span>2009</span><span>,第1卷</span><span>,第3期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译: </span>分布式校园信息网络中的安全环境-香川大学信息网络的现状和安全措施的报告 </p> </li> </ul> <ul> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">专利专利分散型キャンパス情報ネットワークにおけるセキュリティ環境-香川大学情報ネットワークにおけるセキュリティ対策の現状と報告</a> <b>[J]</b> . <span> <a href="">河内一芳,</a> <a href="">曽根計俊,</a> <a href="">川口政秀,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">電子情報通信学会技術研究報告. 情報通信マネジメント. Information and Communication Management .</a> <span>2009</span><span>,第60期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:</span>分布式校园信息网络中的安全环境-香川大学信息网络的现状和安全措施的报告 </p> </li> </ul> </div> </div>--> </div> </div> </div> </div> <div class="right "> </div> </div> <div id="thesis_down_palent" class="downloadBth" style="bottom: 19px;z-index: 999;" onclick="xz('06130439120619','13',6,1,this,'9999',0)" title="专利原文即时下载到本机" prompt="0101301">获取专利</div> <span id="06130439120619down" data-source="6," data-out-id="RU47469U1," data-f-source-id="6" data-title="Tableted LIVE recombinant bivaccine 'REVAKS CGT' against smallpox and hepatitis B to enteral administration" data-price="20" data-transnum="0" style="display:none;"></span> <div class="right_btn"> <ul> <li class="gouwuche"> <!-- <a href="javascript:void(0);" onclick="link_analysis('/shoppingcart/auth/list.html',this)">购物车</a>--> </li> <li class="yijian"> <a href="javascript:void(0);" onclick="link_analysis('/mycenter/auth/complaint.html',this)">意见反馈</a> </li> <li class="top"> <a href="javascript:scrollTo(0,0);">回到顶部</a> </li> <li class="shouye"> <a href="/">回到首页</a> </li> </ul> </div> <div class="xllindexfooter"> <div class="xllindexfootercenter"> <div class="xllindexfooterleft left" > <div class="xllindexfooterleftli"> <ul> <li><a href="/about.html">关于掌桥</a></li> <li><a href="/help/helpmap.html">资源导航</a></li> <li><a href="/help/helpguide.html">新手指南</a></li> <li><a href="/help/helpcenter.html">常见问题</a></li> <li><a href="/sitemap.html">网站地图</a></li> <li><a href="/help/helpcenter.html?type=9">版权声明</a></li> </ul> </div> <div class="xllindexfooterleft"> <p class="xllindexfooterlefteamil">客服邮箱:kefu@zhangqiaokeyan.com</p> <div class="xllindexfooterlefttcp"> <div class="xllindexfooterpoliceiimg"></div> <div class="xllindexfooterpoliceispan"> <span>京公网安备:11010802029741号 </span> <span>ICP备案号:<a href="https://beian.miit.gov.cn" rel="nofollow" target="_blank">京ICP备15016152号-6</a></span> <span>六维联合信息科技 (北京) 有限公司©版权所有</span> </div> </div> </div> </div> <div class="xllindexfooterright left"> <ul> <li> <p style="font-weight: bold;">客服微信</p> <div></div> </li> <li> <p style="font-weight: bold;">服务号</p> <div></div> </li> </ul> </div> </div> </div> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery-1.12.4.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/lwlh_ajax.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zq.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/common.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery.cookie.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/top.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/login.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/down.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/search.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/searchtype.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/user/regist.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zxs_solor/detail.js?v=5.7.7"></script> <script type="text/javascript" src="https://www.zhangqiaokeyan.com/statistics/static/pagecollection.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/tj.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/pushbaidu.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/history.js?v=5.7.7"></script> </body> </html>